500 mg/day investigated
Women’s Midlife Nutrition
Explore women’s midlife formulations informed by published VMK223 research into inflammatory and selected endocrine biomarkers in women aged 40–55.
APPLICATIONS
One postbiotic technology. Multiple formulation possibilities.
VMK223 is a clinically investigated postbiotic ingredient offering formulation opportunities across women's health, beauty-from-within, gut health and healthy ageing. Supported by human research and finished-product development experience, it offers brands a distinctive ingredient to evaluate for their next generation of nutritional products.
APPLICATION AREAS
Explore the possibilities.
500 mg/day investigated
Beauty From Within
Develop differentiated skin-oriented products informed by a standalone human trial reporting instrumental improvements in hydration, elasticity and wrinkle appearance.
200mg/day in Y Gut sensitive formulation
Gut Health
Combine host-centred postbiotic science with microbiota-directed nutrition. Y GUT sensitive illustrates a finished powder combining VMK223 and galactooligosaccharides (GOS).
400mg/d in a 5g/d fibre formulation
Metabolic Health & Healthy Ageing
An emerging development area supported by mechanistic investigation and preliminary human research on a multi-ingredient fibre formulation.
FINISHED-PRODUCT APPLICATIONS
From ingredient technology to finished products.
The Y Collection demonstrates veMico’s experience incorporating VMK223 into consumer-ready capsules and powders. These products illustrate how the ingredient can be used alone or alongside complementary ingredients in differentiated nutritional formulations.
BEAUTY FROM WITHIN · FORMULATION EXAMPLE
Y SKIN — Beauty From Within
A daily beauty-from-within capsule delivering 500 mg VMK223. Developed around veMico’s clinically investigated postbiotic ingredient, Y SKIN demonstrates a convenient consumer-ready application.
Explore Y SKIN consumer experience →
GUT HEALTH · FORMULATION EXAMPLE
Y GUT sensitive — Gut Health
A daily powder combining 200 mg VMK223 with 1.5 g galactooligosaccharides (GOS), bringing together microbiota-directed prebiotic nutrition and host-centred postbiotic technology.
Explore Y GUT consumer experience →NEXT STEP
Discuss an application with veMico.
Tell us about your target population, product format, evidence needs and intended market.
Discuss an application